Summary
Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks Transcript
Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks Transcript
Quantum-Si Incorporated (QSI) Reports Q1 Loss, Misses Revenue Estimates
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.11 per share a year ago.
Quantum-Si incorporated (QSI) Q4 2025 Earnings Call Transcript
Quantum-Si incorporated (QSI) Q4 2025 Earnings Call Transcript
Quantum-Si Incorporated Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 70 | $77 | $61.07 | -$15.93 | -20.69% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 250 | $193.5 | $216.35 | $22.85 | 11.81% |
| BG Bart Gancher Intech Investment Management LLC | 46,486 | $89,642.52 | $40,284.77 | -$49,357.75 | -55.06% |
| YA Yinka Akinsola Blue Trust Inc. | 5,000 | $5,500 | $4,329.5 | -$1,170.5 | -21.28% |
 Jeffery Yorg Focus Partners Advisor Solutions LLC | 16,473 | $12,750.1 | $14,300.21 | $1,550.11 | 12.16% |
Quantum-Si Incorporated (QSI) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Quantum-Si Incorporated ever had a stock split?
Quantum-Si Incorporated Profile
| Biotechnology Industry | Healthcare Sector | Jeffrey Alan Hawkins CEO | NASDAQ (NMS) Exchange | 74765K105 CUSIP |
| US Country | 145 Employees | - Last Dividend | - Last Split | 10 Jun 2021 IPO Date |
Overview
Quantum-Si Incorporated is at the forefront of life sciences innovation, focusing on the development of a cutting-edge single-molecule detection platform designed to revolutionize Next Generation Protein Sequencing (NGPS). Their groundbreaking technology aims to provide deeper insights into protein identification, characterizing protein variants, antibody characterization, biomarker identification, and the analysis of post-translational modifications. Since its inception in 2013, Quantum-Si has established itself in Branford, Connecticut, where it continues to push the boundaries of protein sequencing technology.
Products and Services
- Platinum NGPS Instrument - This core instrument serves as the backbone of Quantum-Si’s technology, facilitating advanced protein sequencing through its innovative single-molecule detection capabilities. The Platinum NGPS instrument is designed for high-throughput analysis, enabling researchers and scientists to glean unprecedented insights into the proteome.
- Platinum Analysis Software Service - Complementing the Platinum NGPS instrument, this software service offers powerful data analysis and interpretation tools. It enables users to efficiently process and understand the complex data generated by the NGPS instrument, facilitating a deeper understanding of protein functions and interactions.
- Reagent Kits and Semiconductor Chips - Essential for the operation of the Platinum NGPS instrument, these reagent kits and semiconductor chips ensure the highest quality of protein sequencing. The specifically designed reagents and chips are tailored to optimize the performance of the NGPS technology, enabling precise and accurate protein analysis.
